SYK Stock Analysis: Buy, Sell, or Hold?
SYK - Stryker Corporation
$311.07
-20.38 (-6.15%)
▼
5d:
-5.66%
30d:
+1.78%
90d:
-10.42%
HOLD
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Jul 30, 2026
14d
Smart Money Accumulation
None View Scanner →
Strength: 5.8/10
Get Alerted When SYK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SYK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SYK shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$510.50
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$316.98
1.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SYK is currently trading at $311.07, which is considered slightly low relative to its 30-day fair value range of $306.07 to $326.12. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.6) compared to its historical average (21.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.9% over the next few years. This pessimistic expectation contrasts with the company's recent 14.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SYK is in a strong downtrend. The price is currently testing key support at $306.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: SYK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $385.92 (+24.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SYK is in a strong downtrend. The price is currently testing key support at $306.53. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.1% recently.
Market Sentiment: SYK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $385.92 (+24.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$306.07 -
$326.12
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
85.7%
Protect Your Profits
Holding SYK? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.1%)
- BULLISH: Trading 24.1% below Wall St target ($385.92)
- CAUTION: Recommendation downgraded due to -5.7% 5-day decline
Trading Range Analysis
30-Day Trading Range
$306.07 -
$326.12
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$306.53
Resistance Level
$336.15
Current Trend
Strong Downtrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.60
Wall Street Target
$385.92
(+24.1%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
14.2%
Profit Margin
13.2%
Valuation Discount vs History
-3.9% cheaper
PE vs Historical
18.6 vs 21.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.9%
(market-implied from PE analysis)
1-Year Target
$298.94
(-4%)
2-Year Target
$287.28
(-8%)
3-Year Target
$276.08
(-11%)
3-Yr Target (if PE normalizes)
(PE: 19→21)
$311.71
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.6%)
$506.65
(+63%)
Base:
(SPY PE: 18.6, Growth: 11.6%)
$432.66
(+39%)
Bear:
(PE: 15.8, Growth: 11.6%)
$367.76
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 38.17 | Current EPS (TTM): $8.64
Bull Case
$702.21
(+126%)
Analyst growth 93.6%, PE expands to 42.0
Base Case
$638.37
(+105%)
Market implied 93.6%, PE stable at 38.2
Bear Case
$224.25
(-28%)
Severe decline -20.0%, PE contracts to 32.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.6 to 21.0
Stabilization Target:
$351.22
(+12.9%)
PE Expansion Potential:
+12.9%
Share & Embed Analysis
Last updated: July 15, 2026 7:47 AM ET
Data refreshes hourly during market hours. Next update: 8:47 AM
Data refreshes hourly during market hours. Next update: 8:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SYK showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-02-17
Ronda E Stryker
SELL
250000 shares
2026-02-04
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 50 HOLD |
Advanced SYK Option Strategies
Professional options setups generated by AI based on today's SYK price and gamma walls.
